Skip to main content

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Michael Flax

Michael Flax is recorded as CEO, Board Member, Chairman and CFO at Nutra Pharma Corp (NPHC). Nutra Pharma Corp reported in an 8-K filed March 22, 2024 that Michael Flax was appointed Chairman of the Board, effective March 20, 2024. Nutra Pharma Corp reported in an 8-K filed March 22, 2024 that Michael Flax was appointed Chief Financial Officer, effective March 20, 2024. Nutra Pharma Corp reported in an 8-K filed March 22, 2024 that Michael Flax was appointed Director, effective March 20, 2024. Equibles holds 4 filed executive changes naming Michael Flax; each is listed under recent activity with its source filing.

“On March 20, 2024, our Board of Directors unanimously approved of the appointment of Michael Flax, DDS as our Chief Executive Officer, Director, Chairman of the Board and Chief Financial Officer.”
Nutra Pharma Corp Form 8-K, filed March 22, 2024 · Read the filing
“On March 20, 2024, our Board of Directors unanimously approved of the appointment of Michael Flax, DDS as our Chief Executive Officer, Director, Chairman of the Board and Chief Financial Officer.”
Nutra Pharma Corp Form 8-K, filed March 22, 2024 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.